- Home
- DNTH vs GDEN Comparison
DNTH vs GDEN Comparison
Compare DNTH & GDEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DNTH | GDEN |
|---|---|---|
| Founded | 2015 | 1998 |
| Country | United States | United States |
| Employees | N/A | 5300 |
| Industry | Biotechnology: Pharmaceutical Preparations | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 741.2M |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | DNTH | GDEN |
|---|---|---|
| Price | $42.19 | $28.16 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 6 |
| Target Price | ★ $68.00 | $32.20 |
| AVG Volume (30 Days) | ★ 744.6K | 341.0K |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 3.54% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.20 |
| Revenue | $3,078,000.00 | ★ $643,485,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.97 |
| P/E Ratio | ★ N/A | $138.44 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $13.37 | $19.57 |
| 52 Week High | $45.46 | $35.49 |
Technical Indicators
Market Signals| Indicator | DNTH | GDEN |
|---|---|---|
| Relative Strength Index (RSI) | 54.91 | 54.21 |
| Support Level | $42.70 | $27.77 |
| Resistance Level | $44.06 | $28.49 |
| Average True Range (ATR) | 1.74 | 0.66 |
| MACD | -0.39 | -0.34 |
| Stochastic Oscillator | 28.78 | 18.57 |
Price Performance
Historical ComparisonAbout DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About GDEN Golden Entertainment Inc.
Golden Entertainment Inc is a U.S. based company that focuses on distributed gaming, casino, and resort operations. Its reportable segments are Nevada Casino Resorts, Nevada Locals Casinos, Nevada Taverns, and Distributed Gaming. The majority of the revenue for the company is generated from its Nevada Casino Resorts segment which is comprised of destination casino resort properties offering a variety of food and beverage outlets, entertainment venues, and other amenities.